ORTHOPEDICS

GENEVA, Aug. 11, 2026 /PRNewswire/ — Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from cervical disc disease.

Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.

Smith+Nephew (NYSE:SNN) announced today that the FDA granted de novo clearance for its TESSA spatial surgery system.

The technology offers a dual-sided design with a nonporous underside and porous polyethylene structure on other sides.

NEWNAN, Ga., July 17, 2026 /PRNewswire/ — Poriferous, LLC, a leading global manufacturer of SuᐧPor® craniomaxillofacial and patient-specific implants, has been awarded its patent for its innovative DuraBloc™ technology from the U.S. Patent and Trademark Office (USPTO), U.S. Patent No. 12,653,677, issued on June 16, 2026.

TORONTO, July 15, 2026 /PRNewswire/ — SpinaFX Medical Inc. (“SpinaFX”), a Toronto‑based medical device company specializing in image‑guided, minimally invasive spine care, today announced it has received Medical Device Regulation (MDR) CE Mark certification for its Triojection® System (MDR 843778).